Skip to main content
Download PDF

Integrated cognitive behavioral treatment for substance use and depressive symptoms: a homeless case series and feasibility study

Pilot and Feasibility Studies volume 9, Article number: 76 (2023) Cite this article

Abstract

Background

Homelessness is associated with high prevalence of psychiatric disorders such as substance use disorders, including alcohol use disorder, and depression.

Methods

This case series and feasibility trial evaluated a novel integrated cognitive behavioral treatment (ICBT), which was adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously. The ICBT was delivered among four homeless individuals enrolled in the Treatment First program (a social services program where treatment is offered in conjunction with temporary transitional housing), who had access to stable and sober housing milieus.

Results

The ICBT was rated high in expectancy of improvement, credibility, and satisfaction, with few treatment-related adverse events, and fairly high treatment retention. At 12 months follow-up, three of four participants were not homeless anymore. Some participants experienced short-term reductions in substance use and/or depressive symptoms.

Conclusions

The study provided preliminary support that the ICBT can be a feasible and potentially effective treatment for homeless individuals with substance use and/or depressive symptoms. However, the delivery format within the Treatment First program was not feasible. The ICBT could be offered within the social services Housing First program instead (where permanent housing is offered before treatment), or to non-homeless individuals.

Trial registration

The study was registered retrospectively at ClinicalTrials.gov (NCT05329181).

Peer Review reports

Key messages regarding feasibility

  • This case series and feasibility trial evaluated a novel integrated cognitive behavioral treatment (ICBT), which was adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously.

  • The ICBT indicated good feasibility on most measures, i.e., expectancy of improvement, credibility and satisfaction, treatment retention, treatment-related adverse events, improved housing status, and potential reductions in substance use (including alcohol use) and symptoms of depression and anxiety.

  • The delivery format within the social services Treatment First program was not optimal. Evaluation of the ICBT within the social services Housing First program, or to comorbid non-homeless participants with SUD and depression, might be considered.

Background

More than 400,000 and 600,000 individuals are homeless in the European Union and the USA, respectively. Homelessness is seen as a complex interaction between individual and structural factors and is associated with poor mental and physical health [1,2,3,4] and increased mortality [5], as well as large costs for society. Definitions of homelessness vary across countries [4]. Sun et al. [6] proposed that the degree of homelessness could be measured and categorized into four groups with different living conditions: (1) Rough sleepers, i.e. homeless individuals who spend the night outdoors, for example in parks, under bridges, in cars or in stair-wells, (2) sheltered homeless, who spend the night in shelters, lodging houses, or so-called low threshold hostels where the guests are allowed to be intoxicated by some drug (including alcohol), (3) homeless in temporary residential institutions, including treatment institutions, where it is usually not allowed to be intoxicated, and (4) homeless close to housing, e.g., persons with a short-time sublease, or a long-term contract with a foundation for those with obstacles on the regular housing market, or someone living in a trial apartment, often arranged by social services, with an option of taking over the rental tenure. According to a similar definition as Sun et al. [6], 32,398 individuals in Sweden were homeless in 2011, and the number of individuals in long-term living arrangements offered by the social services had increased, which constituted almost half of the Swedish homeless population Board and of Health and Welfare [7].

The homeless population is a vulnerable group, specifically due to an increased risk of adverse health-related outcomes, including psychiatric disorders [4]. Swedish studies have estimated the prevalence of alcohol use disorder and/or substance use disorders (henceforth the term SUD will be used, also including alcohol use disorder) in the homeless population to 40–80%, with co-occurring psychiatric disorders between 42 and 50% [8], Board and of Health and Welfare [7]. Although psychiatric disorders have been proposed both as a potential cause and a consequence of homelessness [4, 6], little is known regarding the etiology of co-occurring depression and SUD in the homeless population [9]. In general, it is difficult to draw reliable etiological conclusions due to the chaotic and unstable environments that many homeless individuals are exposed to. Research on concurrent substance use and depressive symptoms among homeless populations is sparse, however, some previous findings have been reported. SUD have been found to be highly correlated with both initiation and persistence of homelessness [10]. Studies have shown that homeless individuals are specifically vulnerable to depression [9]. Social isolation, food deprivation, health- or relationship problems, SUD, low personal resources, self-esteem, or goal orientation are factors that have been discussed as possible explanations to the high prevalence of depression in homeless populations. Increased depressive symptoms, i.e., negative affect, have in general been associated with increased alcohol use [11], and with risk of dropout from SUD treatment among homeless individuals [12].

Swedish social services are typically operating according to the Treatment First program. In this working model, temporary transitional housing is offered using a continuous approach (e.g., non-drug-free emergency shelters or low threshold hostels, or sober residential institutions, trial or train apartments) alongside with psychiatric treatment, mainly for SUD. Access to permanent housing is conditional on “housing readiness” (e.g., being sober or drug-free) and adherence to treatment. Treatment First is the mainstream working model for homelessness in Sweden (i.e., treatment as usual) [10, 13, 14].

Standard mental health treatments are usually considered ineffective for homeless individuals with psychiatric comorbidity, due to insufficient outreach, lack of decent housing, and failure to address pending SUD [15]. Housing plays a key role for homeless individuals to respond to treatment. Access to stable, safe, and sober housing milieus is often seen as a prerequisite for starting treatment. Previous treatment studies for SUD have demonstrated effectiveness when homeless individuals have received simultaneous access to stable, safe, and sober housing milieus [16], and the treatments have been shown to be less effective when such housing milieus have not been offered [17]. According to international recommendations, treatment for homeless individuals should have an integrative approach for co-occurring mental illness and SUD, be tailored to the specific needs of the population, and coordinated in collaboration with other services, such as social workers [18]. According to our knowledge, no such cognitive behavioral treatment protocol exists today.

The aim of this study was to evaluate feasibility of a novel integrated cognitive behavioral treatment (ICBT), which was adapted specifically for homeless individuals and developed to treat substance use and depressive symptoms simultaneously. Feasibility was evaluated in a small sample of homeless individuals in the Treatment First program within the social services (where treatment is offered in conjunction with temporary transitional housing), who had access to “stable housing” (safe and sober housing milieus) during the treatment period. In this study, stable housing was operationalized as situations 3 and 4 according to the definition by [6], i.e., temporary residential institutions, e.g., treatment institutions where it is usually not allowed to be intoxicated, or close to housing, e.g., train or trial apartments arranged by the social services), because we did not want to exclude homeless participants in sober residential institutions. Treatment feasibility was investigated in terms of (1) expectancy of treatment improvement, credibility, and satisfaction,(2) number of completed treatment sessions and cancelled sessions; (3) occurrence of adverse events; (4) improved housing status; (5) reduction in substance use (including alcohol); (6) reduction in symptoms of depression and anxiety; and (7) treatment workload.

Methods

Design

A non-randomized ICBT feasibility study and case series of homeless individuals (n = 4), with measures administered pre and post treatment, weekly during treatment, and at 3-, 6-, and 12-month follow-up. Participants were recruited within a Treatment First program, using convenient sampling.

Participants and study site

All study participants were clients at the social welfare office for the homeless, a specialized unit within the social services in Stockholm, Sweden. The participants were referred to outpatient ICBT at Pelarbacken, a specialized primary care center for homeless patients. Participants were included in the study if they (a) fulfilled the DSM-5 [19] criteria for AUD or SUD, (b) fulfilled the Swedish criteria for homelessness Board and of Health and Welfare [7] and had access to “steady housing” (defined as situation 3 or 4 according to [6], (c) were between 16–65 years old, (d) were able to read and write Swedish and were able to carry out treatment, 5–15 sessions together with homework assignments, and (e) had regular contact with a social worker at the social welfare office for the homeless. Exclusion criteria were (f) another primary psychiatric condition (e.g., bipolar disorder, psychosis, suicidal ideation), (g) failure to attend first two treatment sessions, and (h) other aggravating circumstances, for example violence in close relationships. Recruitment began in June 2016 and ended in January 2017. The last follow-up measure was administrated in July 2018.

In total, six homeless individuals were invited to participate in the study, of which five completed informed consent and were included. One participant started treatment but moved to another city. This participant was removed from the study, as the ethical permit did not cover other cities (or social services) than Stockholm. See Table 1 for baseline demographic characteristics of the four remaining participants.

Table 1 Baseline demographic properties of participants
Full size table

Measures

Acceptability

Perceived credibility and satisfaction of treatment were measured with the Credibility/Expectancy Questionnaire (CEQ; [21] and the Client Satisfaction Questionnaire (CSQ-8, [22], respectively. Higher scores indicate higher treatment credibility and satisfaction. The participants also reported adverse events using a self-report measure adapted for psychological treatment [23]. For each adverse event reported, participant also rated the discomfort caused by the event when it occurred, as well as residual discomfort (level of discomfort at the time of assessment). Ratings were made between 0 (“did not affect me at all”) and 3 (“affected me very negatively”).

The CEQ was administered after treatment session 2, and the CSQ-8 after treatment. The adverse event measure was administered after treatment, and at 3, 6, and 12 months following treatment cessation.

Housing status

Demographic questions were administered pre and post treatment, as well as during follow-up. The degree of homelessness was assessed with the questions “When was the last time that you had a housing of your own?” and”Where did you sleep last night?,” with response alternatives based upon the Swedish national definition of homelessness: “Outside”; “At a shelter”; “In a temporary (sober) residential institution,” “In a reference-based training or trial apartment,” or “In my own apartment (own lease)”. In addition, information of the participants’ housing status was collected from the registers of the social welfare office for the homeless at baseline and follow-up.

Substance use and psychiatric symptoms

The TimeLine Follow Back (TLFB; [24], a retrospective calendar instrument to assess days and quantity of alcohol and drug use, was used as primary measure for substance use. The TLFB have been found to have good psychometric properties in a homeless population [25]. In this study, alcohol and substance use was assessed using a retrospective 90-day calendar interview at baseline, and a retrospective 7-day measure was assessed weekly during treatment sessions. Number of units (alcohol or drug use per week) was reported as means per week during baseline and treatment. The TLFB was not administered at follow-up. The Patient Health Questionnaire (PHQ-9 [26], was used as primary measure for depressive symptoms. The following cut-off categories have been provided for the PHQ-9: none–minimal depression (0–4), mild depression (5–9), moderate depression (10–14), moderately severe depression (15–19), severe depression (20–27).

The Generalized Anxiety Questionnaire (GAD-7; [27], the Alcohol Use Disorders Identification Test (AUDIT, [28], and the Drug Use Disorders Identification Test (DUDIT [29], were used as secondary measures for anxiety, alcohol use, and drug use, respectively.

Primary and secondary measures were administered before and after treatment, as well as at 3, 6, and 12 months following treatment cessation. In addition, the TLFB and the PHQ-9 (1 week interval) were administered weekly during treatment.

Procedure

Prior to inclusion, participants signed an informed consent, including consent for collaboration with the social welfare office for the homeless, and were assessed for psychiatric comorbidity with the Mini International Neuropsychiatric Interview 7.0 (MINI-7; [20]. The individual treatment sessions lasted between 30 and 60 min and were conducted at a location preferred by the participants. Two participants choose to receive the treatment at Pelarbacken, and two participants at another health care clinic and in their homes. In parallel to the treatment, participants received regular health care and social services interventions, such as housing supporters. The first author, a clinical psychologist, assessed and delivered the treatment as face-to face sessions for all participants except one. This participant was assessed with MINI-7 by a psychiatrist at Pelarbacken and had the first 9 treatment sessions delivered by a nurse at Pelarbacken who was trained by the first author, and the last 6 sessions delivered by the first author.

Ethical considerations and safety procedures

The study was conducted in accordance with the Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects and was approved by the Regional Ethics Board of Stockholm, Sweden (ref. no. 2015/2355–31/5). The following steps were taken to ensure participants safety and minimize dropout: (1) The ICBT was delivered at Pelarbacken, a specialized primary care center for homeless patients, with access to a team of health care providers such, physicians, nurses, and psychiatrists; (2) participants had an option to complete the ICBT sessions outside of Pelarbacken, for example as home visits, to reduce contact with alcohol and drug intensive milieus; (3) each ICBT session started with an “emergency list” targeting possible short-term issues that needed to be resolved to continue treatment for example lapses/relapses, medication, economical/housing complications; (4) participants had an option to have between session contact via phone or text messages, as well as weekly text message reminders of sessions; (5) participants that did not improve were offered referral to other treatment, e.g., specialized psychiatric treatment for anxiety; (6) participant’ names, stories and age were modified to ensure confidentiality, and lastly (7) the ICBT was conducted in collaboration with the participants social worker at the social welfare office for the homeless, optional parallel meetings were scheduled together with the participant and their social secretaires to ensure treatment confidentiality and secrecy. This last safety procedure was especially important as homeless individuals within the Treatment First model might risking losing their housing milieu, due to reported substance use.

Analysis and missing data

Six-month follow-up assessment was missing for participant Baako, who was abroad at the occasion for measurement. Twelve-month follow-up was missing for Annelie, due to a relapse of drug use. In addition, assessment of GAD-7 was missing for Annelie at 6-month follow-up, due to a measurement error. These data were presented as not assessed. Three CSQ-8 items were missing for Annelie and were replaced with the respective mean CSQ-8 item score of the other participants. Alcohol, substance use, and depressive symptoms were assessed weekly during treatment sessions. Not assessed weeks were reported and replaced with last observation carried forward (see Fig. 3). As this was a non-randomized feasibility study with only four participants, outcomes were presented using descriptive statistics. TLFB units (alcohol or drug use) were presented in means per week, and self-report measures (PHQ-9, GAD-7, AUDIT and DUDIT) as total scores. All reported adverse events were reviewed and categorized as treatment, or non-treatment related, by author OM. Quantitative analyses were done using R Studio version 1.1.456 [30].

Development of the intervention

The ICBT was developed as part of a collaborate treatment program between the social welfare office for the homeless and Pelarbacken. Initially during the program, homeless individuals were offered relapse prevention for substance use in a group format. Relapse prevention is a cognitive behavioral approach that aims to teach a variety of specific coping skills and decrease individual high-risk situations associated with relapse for substance use (e.g., [31]. However, relapse prevention was not considered optimal as the participants stated that they used alcohol and drugs in “all situations,” as a natural part of the homeless life. Furthermore, post treatment interviews and individual behavioral analyses of prior patients showed that the far most common reason for alcohol or drug use was coping with negative affect (46% reported this reason).

A novel ICBT was developed emanating from the following analysis (1) being homeless often implicates having lost contact with several important life areas, substance use might be the only reinforcing activity left; (2) common reactions are stress and depressive symptoms, and avoidance-based strategies such as passivity, isolation, avoidance of social contact, or substance use; (3) when decreasing substance use, a transient approximate 3-month period of increased “depression-like” symptoms occurs, which might lead to lapses or relapses (this period is also called post-acute abstinence, or protracted abstinence (e.g., [32])). The ICBT (5–15 sessions) was developed to extend over this time period, with the overall aim of participants to (1) access a stable, sober housing milieu, and decrease substance use; (2) learn strategies to cope with negative affect; and (3) learn strategies to cope with life changes, increase activities such as work, social contact, exercise, or leisure activities. Based on the post treatment interviews and individual behavioral analyses of prior patients, and previous research (e.g., [9, 11], we assumed that the intended mechanism of change (for both substance use and depressive symptoms) was reduction of avoidance-based behaviors in relation to negative affect/depressive symptoms. The ICBT included interventions from behavioral activation and relapse prevention (e.g., [31, 33], but did not involve any techniques derived from motivational interviewing (e.g., [34] (see Table 2 for treatment components, Fig. 1 for an example of the treatment content, and Fig. 2 for participants).

Table 2 Components of integrated treatment
Full size table
Fig. 1
figure 1

Example of treatment content

Full size image
Fig. 2
figure 2

Participants

Full size image

Results

Acceptability, treatment sessions, and adverse events

Mean CEQ ratings of treatment credibility (M = 8.38, Sd = 0.89, range 1–9) and expectancy (M = 75%, Sd = 16.90, range 0–100%) after session 2 were high. Satisfaction with treatment was rated in the higher range of CSQ-8, with a mean of 29 (Sd = 3.83) out of 32. Participants received in total 42 treatment sessions (M = 10.5, range 5 to 15). In total, 16 scheduled sessions (28%) were cancelled by the participants (range 0 to 6). In total, five adverse events were reported, of which two were categorized as treatment related (see Table 3).

Table 3 Treatment sessions and adverse events
Full size table

Housing status, substance use, and psychiatric symptoms

No participant lost their housing during the study, due to, e.g., reported alcohol or drug use. Three participants had taken over the lease for their trial apartment and were thus not homeless anymore at 12 months follow-up. One participant, Jennifer, had moved from a training to a trial apartment. Overall, Annelie showed no improvements in psychiatric symptoms. She experienced a relapse for heavy drug use at the time for the 12 months follow-up and did not complete any of the measures, but if she had, all measures would probably have been elevated compared to baseline. All other participants seemed to show some reduction in anxiety from baseline to 12 months follow-up. Drug use patterns, assessed with the DUDIT, seemed similar at baseline compared to 12 months follow-up, or showed some reduction as with participant Baako. Depressive symptoms seemed to reduce continuously for Jennifer and Baako. Adam experienced a lapse or relapse of alcohol use at 12 months follow-up, as well as elevated depressive symptoms (see Table 4) (Fig. 3).

Table 4 Housing status and psychiatric symptoms
Full size table
Fig. 3
figure 3

Substance use and depressive symptoms

Full size image

Discussion

This study evaluated the feasibility of a novel integrated cognitive behavioral treatment (ICBT), adapted for homeless individuals, developed to treat substance use (including alcohol use) and depressive symptoms simultaneously. The ICBT was evaluated among four homeless individuals in the social services Treatment First program. In the Treatment First program homeless clients are offered a temporary accommodation, in conjunction with treatment. In the current study, all participants had access to stable, sober housing milieus, before starting the ICBT, which has been described as a condition for homeless individuals to be able to engage in treatment [35]. Previous substance use treatment studies among homeless individuals have shown good results when housing have been offered simultaneously [16], and been less effective when only treatment have been offered [17].

The ICBT was rated high in expectancy, credibility, and satisfaction, with few treatment-related adverse events. No participant dropped out of the treatment (not counting the participant who moved to another city and was removed from the study, due to geographical limitations in the ethical permit). In total, the number of completed treatment sessions was fairly high (n = 42, 72%), and the scheduled dropout sessions fairly low (n = 16, 28%). Previous studies have shown that treatment retention is difficult among homeless individuals, only about 25–33% complete treatments for substance use, even though the treatment programs are tailored especially to the needs of the population [36]. One possible explanation for treatment retention in this study could be that several recommended strategies to engage homeless individuals [37] were used in conjunction with treatment, such as offering a safe environment and outreach (home visits). Another possible explanation consists of the content of the treatment. Ibabe et al. [12] found that recent emotional stress among homeless individuals predicted less participation in substance use treatment compared to substance use alone, which predicted significantly more participation in treatment. In the current study, substance use and depressive symptoms were treated simultaneously using a behavioral activation approach (e.g., [33], thus addressing recent and emerging emotional stress, continuously. Finally, although this was a small, non-randomized feasibility study which did not permit causal inference, the results indicated that some participants experienced short-term reductions in substance use, and/or depressive symptoms. Overall, we conclude that the ICBT can be a feasible and potentially effective treatment for homeless individuals, which needs to be evaluated in larger controlled studies.

The delivery format within the Treatment First program was not optimal. Access to permanent housing within the Treatment First program is conditional on “housing readiness” and adherence to treatment (e.g., being sober or drug-free), while substance use might lead to losing a temporary housing milieu, such as trial or train apartments. Notably, three of four participants were not homeless at the end of the study, although the majority reported substance use during the ICBT, while they had access to sober trial and training apartments. As such, it is possible that the principle of “housing readiness” was applied less rigorously at the study site. Still, the condition of “housing readiness” within the Treatment First program can be seen as non-compatible with several treatment principles of the ICBT, such as voluntariness (own goals), or natural occurrences of lapses and relapses. In term of study workload, one clinical psychologist (OM) conducted practically all clinical assessments, treatment sessions, and scheduling, including a range of procedures designed to ensure treatment confidentiality and safety within the Treatment First program, such as home visits and cooperation with social workers and other health care clinics. These procedures might have increased participant safety and decreased dropout, cancelled visits and adverse events, but the workload surrounding treatment deliverance in this study seemed beyond regular clinical praxis. A further unexpected treatment obstacle was that half of the participants expressed that it was stressful to complete the ICBT, in relation to work, other health care visits, and mandatory measures within the Treatment First program, such as housing supporters. At the time of the study, the Housing First program was being implemented at the study site [14]. In the Housing First model, permanent housing is being offered as a first step [10, 13]. Continuous support is also offered, but housing is not contingent on adherence to psychiatric treatment or substance abstinence. Incorporating the ICBT into support systems of Housing First programs instead, for example in an Assertive Community Treatment team (an interdisciplinary Housing First team with healthcare professionals and social workers), could potentially increase feasibility from a treatment deliverance perspective. If so, it would be ensured that engagement in treatment is voluntary (i.e., not a conditioned measure to get access to housing). It would also be possible to coordinate and plan different interventions tailored to the participants needs and reduce the necessity of several safety procedures employed in this study, as well as reduce workload for the treatment deliverer. It would also enable possibility for “on demand” treatment interventions, to address, e.g., lapses and relapses, as support is continuously offered after participants get access to permanent housing. Unfortunately, Treatment First is still the mainstream working model [14], and only a monitory of the homeless population is being offered Housing First at the study site. Therefore, studies evaluating the ICBT within the Housing First program were not possible to conduct.

Although the focus of the ICBT was substance use and depressive symptoms, all participants in the current study also suffered from anxiety. This was not necessarily a problem, as behavioral activation (the main treatment component) may also be effective for anxiety disorders [33]. However, three of four participants suffered from post-traumatic stress disorder, for which this treatment was not sufficient. An alternative treatment approach to adapt for homeless individuals could have been prolonged exposure [38], which also have been evaluated in an integrated format for substance use [39].

This study was conducted among homeless participants receiving standard social service and health care interventions, and thus had high ecological validity. Several safety procedures were employed that ensured participant safety and treatment confidentiality within the Treatment First program, which was another strength of this study. Lastly, treatment was developed based upon behavior analysis of homeless participants and addressed an important gap identified in previous research [18]. Notably, comorbidity for SUD and depressive symptoms are not only common among homeless individuals. A recent meta-analysis among non-homeless community and clinical samples found that the pooled prevalence of any SUD in major depression was 25% (with AUD having the highest pooled prevalence of 21%) and that these comorbidity rates had not changed over the past three decades [40]. National treatment recommendations in Sweden [41] recommend integrated treatment for AUD and depression. No such cognitive behavioral treatment protocols exist today according to our knowledge. From this perspective, treatment development for specific vulnerable groups such as homeless individuals can be beneficial also for other patient populations.

Some study limitations are noted. Although the ICBT aimed to address substance use and depressive symptoms simultaneously, fulfilling MDD was not an inclusion criterion in the study, which would have been preferable. Another study limitation was that interviews were not conducted at follow-up due to practical reasons, and therefore the primary measure to assess substance use (TLFB) was not administered at these measure points. Further, depressive symptoms were not assessed at baseline using the same retrospective 12-week time period as the TLFB. Using a multiple baseline design [42] would have improved these measurement issues and ensured better experimental control. Finally, author OM developed the ICBT and administered the treatment and the data collection, thus allegiance bias cannot be ruled out.

Further studies could evaluate the ICBT in homeless samples in Housing First programs, or among comorbid non-homeless participants with SUD and depression.

Availability of data and materials

Dataset sharing is not possible due to integrity reasons, as the study participants were patients in routine health care.

Abbreviations

APD:

Antisocial personality disorder

AG:

Agoraphobia

AUD:

Alcohol use disorder

AUDIT:

The Alcohol Use Disorders Identification Test

CEQ:

The Credibility/Expectancy Questionnaire

CSQ-8:

The Client Satisfaction Questionnaire

DUDIT:

The Drug Use Disorders Identification Test

GAD:

Generalized anxiety disorder

GAD-7:

The Generalized Anxiety Questionnaire

ICBT:

Integrated Cognitive Behavioral Treatment for substance use and depressive symptoms

MDD:

Major depressive disorder

MINI-7:

The Mini International Neuropsychiatric Interview 7.0

OCD:

Obsessive compulsive disorder

PDA:

Panic disorder with agoraphobia

PHQ-9:

The Patient Health Questionnaire

PTSD:

Post-traumatic stress disorder

SAD:

Social anxiety disorder

SUD:

Substance use disorders

TLFB:

The TimeLine Follow Back

References

  1. Beijer U, Andréasson S. Physical diseases among homeless people: gender differences and comparisons with the general population. Scandinavian J Publ Health. 2009;37(1):93–100.

    Article  Google Scholar 

  2. Beijer U, Andréasson S. Gender, hospitalization and mental disorders among homeless people compared with the general population in Stockholm. Eur J Pub Health. 2010;20(5):511–6.

    Article  Google Scholar 

  3. Beijer U, Wolf A, Fazel S. Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(11):859–70.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fazel S, Geddes JR, Kushel M. The health of homeless people in high-income countries: descriptive epidemiology, health consequences, and clinical and policy recommendations. Lancet. 2014;384(9953):1529–40. https://doi.org/10.1016/s0140-6736(14)61132-6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Beijer U, Andreasson S, Ågren G, Fugelstad A. Mortality and causes of death among homeless women and men in Stockholm. Scandinavian J Public Health. 2011;39(2):121–7.

    Article  Google Scholar 

  6. Sun S, Irestig R, Burstrom B, Beijer U, Burstrom K. Health-related quality of life (EQ-5D) among homeless persons compared to a general population sample in Stockholm County, 2006. Scand J Public Health. 2012;40(2):115–25. https://doi.org/10.1177/1403494811435493.

    Article  PubMed  Google Scholar 

  7. The Swedish National Board of Health and Welfare. Homelessness and exclusion from the housing market 2011—Scope and character. 2011.

    Google Scholar 

  8. Halldin J. En klinisk pilotstudie av 35 hemlösa i Stockholm [A Clinical Study of 35 Homeless People in Stockholm]. Social Medicine, Stockholm County & Karolinska Institutet. 2001.

  9. Belcher JR, DiBlasio FA. The needs of depressed homeless persons: designing appropriate services. Commun Ment Health J. 1990;26(3):255–66. https://doi.org/10.1007/BF00752776.

    Article  CAS  Google Scholar 

  10. Patterson ML, Somers JM, Moniruzzaman A. Prolonged and persistent homelessness: multivariable analyses in a cohort experiencing current homelessness and mental illness in Vancouver, British Columbia. Ment Health Subst Use. 2012;5(2):85–101. https://doi.org/10.1080/17523281.2011.618143.

    Article  Google Scholar 

  11. Witkiewitz K, Villarroel NA. Dynamic association between negative affect and alcohol lapses following alcohol treatment. J Consult Clin Psychol. 2009;77(4):633–44. https://doi.org/10.1037/a0015647.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ibabe I, Stein JA, Nyamathi A, Bentler PM. Predictors of substance abuse treatment participation among homeless adults. J Subst Abuse Treat. 2014;46(3):374–81. https://doi.org/10.1016/j.jsat.2013.10.008.

    Article  PubMed  Google Scholar 

  13. Baxter AJ, Tweed EJ, Katikireddi SV, Thomson H. Effects of Housing First approaches on health and well-being of adults who are homeless or at risk of homelessness: Systematic review and meta-analysis of randomised controlled trials. J Epidemiol Community Health. 2019;73(5):379–87.

    Article  PubMed  Google Scholar 

  14. Blid M, Beijer U, Källmén H. The emergence and dissemination of Housing First in Sweden. Homelessness as unfairness. 2020:107–111.

  15. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ. Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis. 1997;185(5):298–305. https://doi.org/10.1097/00005053-199705000-00003.

    Article  CAS  PubMed  Google Scholar 

  16. Smith JE, Meyers RJ, Delaney HD. The community reinforcement approach with homeless alcohol-dependent individuals. J Consult Clin Psychol. 1998;66(3):541–8. https://doi.org/10.1037//0022-006x.66.3.541.

    Article  CAS  PubMed  Google Scholar 

  17. Slesnick N, Prestopnik JL, Meyers RJ, Glassman M. Treatment outcome for street-living, homeless youth. Addict Behav. 2007;32(6):1237–51. https://doi.org/10.1016/j.addbeh.2006.08.010.

    Article  PubMed  Google Scholar 

  18. Hwang SW, Burns T. Health interventions for people who are homeless. Lancet. 2014;384(9953):1541–7. https://doi.org/10.1016/s0140-6736(14)61133-8.

    Article  PubMed  Google Scholar 

  19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). 2013.

    Book  Google Scholar 

  20. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57.

    CAS  PubMed  Google Scholar 

  21. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73–86. https://doi.org/10.1016/S0005-7916(00)00012-4.

    Article  CAS  PubMed  Google Scholar 

  22. Attkisson CC, Greenfield TK. Client Satisfaction Questionnaire-8 and Service Satisfaction Scale-30. In: The use of psychological testing for treatment planning and outcome assessment. Lawrence Erlbaum Associates, Inc. 1994. pp. 402–420

  23. Ljótsson B, Hesser H, Andersson E, Lackner JM, El Alaoui S, Falk L, Aspvall K, Fransson J, Hammarlund K, Löfström A, Nowinski S, Lindfors P, Hedman E. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome. Behav Res Ther. 2014;55:27–39. https://doi.org/10.1016/j.brat.2014.01.007.

    Article  PubMed  Google Scholar 

  24. Martin-Willett R, Helmuth T, Abraha M, Bryan AD, Hitchcock L, Lee K, Bidwell LC. Validation of a multisubstance online Timeline Followback assessment. Brain Behavior. 2020;10(1):e01486.

    Article  PubMed  Google Scholar 

  25. Sacks YJA, Drake ER, Williams FV, Banks MS, Herrell MJ. Utility of the time- line follow- back to assess substance use among homeless adults. J Nerv Ment Dis. 2003;191(3):145–53. https://doi.org/10.1097/01.NMD.0000054930.03048.64.

    Article  PubMed  Google Scholar 

  26. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166(10). https://doi.org/10.1001/archinte.166.10.1092

  28. Saunders JB, Aasland OG, Babor TF, de La Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test ( AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption–II. Addiction (Abingdon, England). 1993;88(6):791.

    Article  CAS  PubMed  Google Scholar 

  29. Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test ( DUDIT) in Criminal Justice and Detoxification Settings and in a Swedish Population Sample. Eur Addict Res. 2005;11(1):22–31. https://doi.org/10.1159/000081413.

    Article  PubMed  Google Scholar 

  30. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2018. https://www.R-project.org/.

  31. Hendershot CS, Witkiewitz K, George WH, Marlatt GA. Relapse prevention for addictive behaviors. Subst Abuse Treatment Prev Policy. 2011;6:1–17.

    Google Scholar 

  32. Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: Are they linked? Addict Biol. 2010;15(2):169–84. https://doi.org/10.1111/j.1369-1600.2009.00194.x.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Stein AT, Carl E, Cuijpers P, Karyotaki E, Smits JAJ. Looking beyond depression: a meta-analysis of the effect of behavioral activation on depression, anxiety, and activation. Psychol Med. 2020: 1–14. https://doi.org/10.1017/S0033291720000239

  34. Noonan WC, Moyers TB. Motivational interviewing. J Subst Misuse. 1997;2(1):8–16.

    Article  Google Scholar 

  35. Källmén H, Blid M.,Jalling C. Utvärdering av Bostad Först för hemlösa i Stockholms stad och Helsingborg. En jämförelse med Boendetrappan. 2014.

  36. Caton LM, Wilkins C, Anderson J. Toward understanding homelessness: The 2007 National Symposium on Homelessness Research: people who experience long-term homelessness: characteristics and interventions. 2007.

  37. Zerger S. Substance abuse treatment: what works for homeless people. A Review of the Literature. Nashville: National Health Care for the Homeless Council; 2002.

    Google Scholar 

  38. Foa EB. Prolonged exposure therapy: past, present, and future. Depress Anxiety. 2011;28(12):1043–7. https://doi.org/10.1002/da.20907.

    Article  PubMed  Google Scholar 

  39. Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: a randomized clinical trial in military veterans. Addict Behav. 2019;90:369–77. https://doi.org/10.1016/j.addbeh.2018.11.032.

    Article  PubMed  Google Scholar 

  40. Hunt GE, Malhi GS, Lai HMX, Cleary M. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990–2019: Systematic review and meta-analysis. J Affect Disord. 2020;266:288–304. https://doi.org/10.1016/j.jad.2020.01.141.

    Article  PubMed  Google Scholar 

  41. The Swedish National Board of Health and Welfare. National Guidelines for Care and Support in Addiction and Addiction - Support for Governance and Management. 2017.

    Google Scholar 

  42. Smith JD. Single-case experimental designs: a systematic review of published research and current standards. Psychol Methods. 2012;17(4):510–50. https://doi.org/10.1037/a0029312.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would first and foremost like to thank the participants in the study. The authors would also like to thank Yanqiu Yu for contributing with statistical support. Finally, author OM would like to thank street-doctors Robert Irestig and Rolf Byström, and dentist Patricia de Palma, for showing the way.

Funding

Open access funding provided by Karolinska Institute. This study was funded by internal founds of Ersta diakoni.

Author information

Authors and Affiliations

  1. PelarbackenErsta Diakoni, Social Welfare Office for the Homeless, City of Stockholm, Stockholm, Sweden

    Olof Molander

  2. Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Norra Stationsgatan 69, Plan 7, 113 64, Stockholm, Sweden

    Olof Molander, Johan Bjureberg, Hanna Sahlin, Ulla Beijer & Clara Hellner

  3. Department of Clinical Neuroscience, Division of Psychology, Karolinska Institutet, Stockholm, Sweden

    Brjánn Ljótsson

Authors
  1. Olof Molander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johan Bjureberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanna Sahlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ulla Beijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clara Hellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Brjánn Ljótsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Author OM conceived of the study, developed the treatment, and treated the participants. Author JB, HS, and BL aided in the research design and ethical application. Author UB gave theoretical input. Author OM wrote a draft version of the manuscript. All authors contributed equally to the final manuscript. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Olof Molander.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Regional Ethics Board of Stockholm, Sweden (ref. no. 2017/1479–31). All participants signed an informed consent before enrolled in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Molander, O., Bjureberg, J., Sahlin, H. et al. Integrated cognitive behavioral treatment for substance use and depressive symptoms: a homeless case series and feasibility study. Pilot Feasibility Stud 9, 76 (2023). https://doi.org/10.1186/s40814-023-01305-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40814-023-01305-2

Keywords

Pilot and Feasibility Studies

ISSN: 2055-5784